Sign in

    Foram Parekh

    Research Analyst at Bank of Baroda

    Foram Parekh is an Analyst at Bank of Baroda, specializing in equity research and sector analysis with a primary focus on Indian banking and financial services companies. She covers prominent firms such as State Bank of India, HDFC Bank, ICICI Bank, and Axis Bank, providing detailed research reports and investment recommendations that have contributed to positive portfolio returns and strong client engagement. Foram began her career in financial analysis in the late 2010s, joining Bank of Baroda in 2021 after prior experience at reputed financial institutions. She holds multiple professional credentials including certifications in securities and investment analysis, highlighting her commitment to industry standards and analytical excellence.

    Foram Parekh's questions to DR REDDYS LABORATORIES (RDY) leadership

    Foram Parekh's questions to DR REDDYS LABORATORIES (RDY) leadership • Q1 2026

    Question

    Foram Parekh from Bank of Baroda asked about the EBITDA margin for the NRT business, the growth outlook for the European business excluding NRT, and the potential size of the obesity market in India post-semaglutide launch.

    Answer

    CEO Erez Israeli confirmed that the EBITDA margin for the NRT business is expected to be around 25%. He projected the European business to deliver double-digit growth, which will accelerate with biosimilar launches. While he declined to quantify the Indian obesity market, he stated the unmet need is very clear and the opportunity is significant.

    Ask Fintool Equity Research AI